VP, Market Access

California, US residents click here.

The job details are as follows:

Who We Are

We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.

United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).

The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.

Who You Are

The VP, Market Access provides enterprise-level leadership for United Therapeutics' Managed Markets & Reimbursement function, with a dual focus on the company's robust small molecule commercial business and pipeline, as well as its pioneering organ manufacturing (biologic) programs. This role sets the strategic vision for market access and pricing, developing and executing innovative, compliant strategies that ensure optimal patient access, coverage, and reimbursement across all U.S. payer channels (commercial, Medicare/Medicaid, VA/DoD, and emerging value-based care models). The VP is accountable for aligning UT's growth objectives and long-term business goals with evolving market realities, including the Inflation Reduction Act, PBM dynamics, and the rise of specialty and rare disease therapies. The role also supports the launch and commercialization of next-generation organ manufacturing solutions, including xenotransplantation and bioengineered organs, positioning UT as a leader in both pharmaceuticals and regenerative medicine.

Strategic Leadership & Vision:

• Define and lead the overall market access strategy for UT’s small molecule and organ manufacturing portfolios, ensuring optimal coverage, reimbursement, and affordability in alignment with corporate growth objectives and the company’s public benefit mission
• Anticipate and respond to evolving payer and policy landscapes, including the impact of the Inflation Reduction Act, 340B program expansion, and the increasing role of PBMs in formulary management and rebate negotiations
• Develop and execute pre-launch and launch market access strategies for new small molecule and biologic products, including organ manufacturing innovations, leveraging real-world evidence, value-based contracting, and patient-centric approaches

Market Access Execution:

• Establish frameworks for pricing, contracting, and payer engagement that maximize access and net revenue performance, with a focus on gross-to-net optimization and mitigation of GTN erosion
• Oversee government pricing compliance and contracting strategies to mitigate risk and maintain regulatory integrity, especially as new biologic and organ manufacturing therapies enter the market
• Ensure governance and compliance across all market access activities, including adherence to evolving fair market value standards for enhanced pharmacy and patient support services

Cross-Functional & External Collaboration:

• Partner with Commercial, Finance, Health Economics & Outcomes Research, Policy, and R&D teams to integrate market access considerations into brand planning, lifecycle management, and pipeline prioritization
• Provide strategic guidance on payer messaging, value propositions, and evidence generation to support negotiations, formulary positioning, and innovative access models (e.g., direct-to-patient, digital health integration)
• Engage externally with industry associations, policy forums, and payer organizations to influence market access trends, advocate for patient access, and shape the regulatory environment for both small molecules and organ manufacturing solutions

Market Intelligence & Performance Management:

• Monitor market trends, policy changes, and competitive dynamics—including biosimilar and generic competition, patent cliffs, and the rise of specialty pharmacy—to identify opportunities and risks impacting access and pricing
• Maintain executive-level communication on market access performance, emerging opportunities, and strategic priorities, ensuring leadership is informed of significant developments and implications
• Manage departmental budget and resource allocation to ensure operational efficiency and strategic impact

Team Leadership:

• Direct and manage direct reports, including responsibilities for training, goal setting, performance management, coaching, mentoring, and career development, supporting recruitment and retention of top market access talent

Minimum Requirements

• Bachelor’s Degree
• 15+ years in pharmaceutical, biotechnology, or related healthcare sectors with a focus on market access, managed markets, and/or reimbursement
• 8+ years in managed care sales, national accounts, or managed care marketing
• 8+ years of progressive leadership experience
• Extensive experience in managed care strategy, including sales, national accounts, contracting, and payer marketing
• Proven track record in developing and executing managed care business plans and integrating strategies with marketing and field sales
• Demonstrated success in contract strategy, negotiation, and analysis, as well as executive-level engagement with payer organizations
• Leadership experience managing managed care or national accounts teams and influencing cross-functional stakeholders
• Deep understanding of payer systems, reimbursement policy, and pricing dynamics, including the unique challenges and opportunities for small molecules and biologics

Preferred Qualifications

• Master’s Degree or additional scientific/clinical credentials
• Advanced data and financial modeling, forecasting, and analysis

Location

United Therapeutics has the flexibility to hire this role remotely within the United States with a preference to candidates in RTP, NC. 

At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.

Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities

United Therapeutics  Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.